Cidara
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Cidara and buy or sell other stocks, ETFs, and their options commission-free!About CDTX
Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system.
CEOJeffrey L. Stein, PhD
CEOJeffrey L. Stein, PhD
Employees38
Employees38
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2012
Founded2012
Employees38
Employees38
CDTX Key Statistics
Market cap345.28M
Market cap345.28M
Price-Earnings ratio-18.79
Price-Earnings ratio-18.79
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$221.42
52 Week high$221.42
52 Week low$15.22
52 Week low$15.22
Stock Snapshot
The current Cidara(CDTX) stock price is $11.77, with a market capitalization of 345.28M. The stock trades at a price-to-earnings (P/E) ratio of -18.79.
Cidara(CDTX) stock opened on 2026-03-15 at —. The price climbed to — and dipped to —.
Cidara(CDTX) shares are trading with a volume of 0.
In the last year, Cidara(CDTX) shares hit a 52-week high of $221.42 and a 52-week low of $15.22.
In the last year, Cidara(CDTX) shares hit a 52-week high of $221.42 and a 52-week low of $15.22.
People also own
Based on the portfolios of people who own CDTX. This list is generated using Robinhood data, and it’s not a recommendation.